Dr. Derek R. Hanson, M.D.
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
At a glance
- In the NPI registry since
- 2008
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
MA license 258393 · NY license 260875
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 2 companies reported 32 payments worth $53,380 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $48,748 |
|---|---|
| Day One Biopharmaceuticals | $4,633 |
| Compensation for services other than consulting (speaking, faculty) | $45,880 |
|---|---|
| Honoraria | $2,998 |
| Travel and Lodging | $2,432 |
| Consulting Fee | $1,635 |
| Food and Beverage | $436 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $3,720 |
| Alexion Pharmaceuticals, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $3,100 |
| Day One Biopharmaceuticals Oct 8, 2025 | Honoraria OJEMDA · ONCOLOGY | $2,998 |
| Alexion Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
All 28 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Day One Biopharmaceuticals Dec 18, 2025 | Consulting Fee OJEMDA · ONCOLOGY | $1,635 |
| Alexion Pharmaceuticals, Inc. Dec 11, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Dec 10, 2025 | Travel and Lodging travel to Boston, MA | $301 |
| Alexion Pharmaceuticals, Inc. Dec 10, 2025 | Travel and Lodging travel to Brookline, MA · in-kind Company’s descriptionSpeaker Expenses | $196 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,860 |
| Day One Biopharmaceuticals Oct 8, 2025 | Honoraria OJEMDA · ONCOLOGY | $2,998 |
| Alexion Pharmaceuticals, Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $3,100 |
| Alexion Pharmaceuticals, Inc. Jul 21, 2025 | Travel and Lodging KOSELUGO · Oncology · travel to Morristown, NJ | $39.20 |
| Alexion Pharmaceuticals, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Jun 4, 2025 | Travel and Lodging travel to Canadaigua, NY | $375 |
| Alexion Pharmaceuticals, Inc. Jun 4, 2025 | Travel and Lodging travel to Canandaigua, NY · in-kind Company’s descriptionSpeaker Expenses | $351 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,960 |
| Alexion Pharmaceuticals, Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $1,860 |
| Alexion Pharmaceuticals, Inc. Apr 29, 2025 | Travel and Lodging travel to Plymouth, MA | $330 |
| Alexion Pharmaceuticals, Inc. Apr 29, 2025 | Travel and Lodging travel to Plymouth, MA | $330 |
| Alexion Pharmaceuticals, Inc. Apr 29, 2025 | Travel and Lodging travel to Plymouth, MA · in-kind Company’s descriptionSpeaker Expenses | $200 |
| Alexion Pharmaceuticals, Inc. Apr 29, 2025 | Travel and Lodging travel to Plymouth, MA · in-kind Company’s descriptionSpeaker Expenses | $200 |
| Alexion Pharmaceuticals, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) KOSELUGO · Oncology Company’s descriptionSpeaker Fee | $3,720 |
| Alexion Pharmaceuticals, Inc. Mar 20, 2025 | Travel and Lodging KOSELUGO · Oncology · travel to Melville, NY | $72.80 |
| Alexion Pharmaceuticals, Inc. Mar 20, 2025 | Travel and Lodging KOSELUGO · Oncology · travel to Melville, NY | $36.44 |
| Alexion Pharmaceuticals, Inc. Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,240 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $91,390 in research payments for these studies, mostly to the institutions running them.
- A Phase 1 Trial of Optune NovoTTF-200A System with and without Concomitant Temozolomide and Bevacizumab in Pediatric Patients with High Grade Glioma
Novocure Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.